DHT and Male Pattern Baldness: The Hormone Behind 95% of Hair Loss

If you've spent any time reading about hair loss, you've seen the letters DHT. They get tossed around like everyone already knows what they mean — and most of the time they're used vaguely. Here's the actual mechanism, why it matters, and how each major treatment targets a specific point in the DHT pathway.

What DHT actually is

DHT — dihydrotestosterone — is a hormone your body makes by converting testosterone using an enzyme called 5-alpha-reductase. DHT is more potent than testosterone at certain androgen receptors. It's essential during puberty (it drives genital development, facial hair, and voice changes), but in adulthood it has fewer useful jobs.

DHT does not destroy hair follicles. What it does is bind to androgen receptors on the follicles in genetically susceptible scalp regions, triggering a process called miniaturization. Over many cycles, the follicle produces progressively shorter, thinner, lighter hairs until eventually it stops producing visible hair entirely.

Why some follicles are susceptible and others aren't

The follicles on your scalp are not all the same. The ones on the top and crown are genetically programmed to express more androgen receptors and respond more strongly to DHT. The follicles on the back and sides — the 'donor area' — are genetically resistant. This is why men who go completely bald on top still keep their wraparound horseshoe.

This donor-recipient distinction is also why hair transplants work. Transplanting DHT-resistant follicles into susceptible areas creates permanent hair in the recipient site, because the follicle itself carries its genetic resistance with it.

How treatments target the DHT pathway

Each major hair loss treatment intervenes at a specific point:

• Finasteride: blocks the 5-alpha-reductase type II enzyme, reducing serum DHT by ~70%
• Dutasteride: blocks both type I and type II 5-alpha-reductase, reducing DHT by ~90%
• Saw palmetto: weakly inhibits 5-alpha-reductase (plant-based, smaller effect)
• Ketoconazole: locally antagonizes the androgen receptor at the follicle
• Topical finasteride: blocks 5-alpha-reductase locally at the scalp with less systemic absorption
• Topical minoxidil: bypasses DHT entirely — it doesn't lower DHT but extends the growth phase regardless

Why blocking DHT works (and what it doesn't fix)

Reducing DHT halts the miniaturization process. Follicles that are still cycling will recover. Follicles that have already been miniaturized to dormancy may not. This is why early treatment matters so much: a partially miniaturized follicle can be rescued; a fully dormant one usually can't.

Blocking DHT also doesn't address other causes of hair loss — telogen effluvium from stress, scarring alopecia, autoimmune conditions, or thyroid disorders. If your loss pattern is unusual (rapid, patchy, painful, or inflammatory), DHT may not be the main driver and a dermatologist visit is warranted before assuming AGA.

The side effect calculus

Because DHT plays roles outside the scalp — particularly in sexual function — systemic DHT blockers like oral finasteride and dutasteride carry small but real risks of decreased libido, erectile dysfunction, and ejaculatory volume changes. Most users tolerate the medication well, but a small percentage (~1–4% in trials) experience these effects, and an even smaller subset report persistence after discontinuation.

This is the central reason topical finasteride is gaining traction: it inhibits 5-alpha-reductase at the follicle level with much lower systemic DHT suppression. The efficacy appears comparable to oral in recent trials.

Affiliate disclosure: Some links on this page are affiliate links. We may earn a commission if you purchase through them at no extra cost to you. Our editorial picks are independent. Read our policy.